Loading…
FEMY
Femasys Inc
NASDAQ· Healthcare· Medical Instruments & Supplies· CUSIP 31447E204
$3.20+14.70%Price as of Aug 29, 18:45 UTC · updated once a day, after the close
Key metrics
- Market cap
- $26.8M
- P/E
- —
- Forward P/E
- —
- P/B
- 2.4x
- Dividend yield
- —
- Payout
- —
- EPS
- -$3.10
- ROE
- -424.97%
- Profit margin
- 0.00%
- Revenue growth
- -18.90%
- Beta
- -2.09
- 52-week high
- $22.20
- 52-week low
- $2.02
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -98.2% over 5Y.
today you would have $18.00▼ -98.2%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $11.52 | $22.00 | $19.50 | $18.00 | |
| P/S | 15.4x | 15.0x | 15.8x | 19.7x | 8.9x |
| P/B | 3.5x | 5.8x | 11.1x | 1.2x | 0.7x |
| EPS | -$9.40 | -$17.00 | -$18.60 | -$19.20 | |
| Profit margin | -1049.82% | -812.27% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ARAYAccuray Inc | $0.23 | — | 0.6x | — | -80.08% | $26.93M |
| LTRNLantern Pharma Inc. | $2.07 | — | — | — | -400.92% | $26.46M |
| BEATHeartBeam, Inc. | $0.47 | — | 3.2x | — | -328.44% | $26.31M |
| BYSIBeyondSpring Inc. | $0.67 |
About the company
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
- 51
- Suwanee, United States
Company description provided by Yahoo Finance.